Pictet Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.6M | Buy |
751,977
+456,384
| +154% | +$25.2M | 0.04% | 346 |
|
|
2025
Q1 | $14.3M | Sell |
295,593
-918
| -0.3% | -$44.4K | 0.02% | 571 |
|
|
2024
Q4 | $11.4M | Buy |
296,511
+289,213
| +3,963% | +$11.2M | 0.01% | 624 |
|
|
2024
Q3 | $328K | Buy |
7,298
+1,450
| +25% | +$65.3K | ﹤0.01% | 1560 |
|
|
2024
Q2 | $203K | Buy |
+5,848
| New | +$203K | ﹤0.01% | 1760 |
|